(NASDAQ: IDXX) Idexx Laboratories's forecast annual revenue growth rate of 9.73% is forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 7.31%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.08%.
Idexx Laboratories's revenue in 2024 is $3,660,953,000.On average, 5 Wall Street analysts forecast IDXX's revenue for 2024 to be $331,695,550,902, with the lowest IDXX revenue forecast at $330,911,768,771, and the highest IDXX revenue forecast at $332,626,484,326. On average, 5 Wall Street analysts forecast IDXX's revenue for 2025 to be $366,090,400,167, with the lowest IDXX revenue forecast at $362,685,148,065, and the highest IDXX revenue forecast at $370,973,729,267.
In 2026, IDXX is forecast to generate $402,310,141,506 in revenue, with the lowest revenue forecast at $396,236,640,113 and the highest revenue forecast at $408,981,720,264.